Literature DB >> 21562376

Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention.

David D McManus1, Amir Y Shaikh, Fnu Abhishek, Ramachandran S Vasan.   

Abstract

Heart failure (HF) and atrial fibrillation (AF) are 2 of the most common cardiovascular diseases encountered in clinical practice, and the prevalence of these diseases continues to grow worldwide with the aging of the global population. While recognizing that AF is a heterogeneous disorder, we submit that the parallels between AF and HF may arise because many cases of AF and HF result from the cumulative exposure of the atria and ventricles to a common set of systemic cardiovascular risk factors. Over time, exposure to risk factors promotes development of atrial and ventricular structural and functional abnormalities through activation of several biologic pathways in concert: upregulation of neurohormonal signaling cascades, release of inflammatory mediators, programmed cell death, and fibrosis. Cardiac structural remodeling occurs in concert with electrophysiologic remodeling, both of which contribute to atrial and ventricular rhythm disturbances, including AF. AF and HF, instead of representing distinct disease processes, often represent different endpoints along a disease continuum. By reviewing some of the mechanistic parallels between AF and HF, we hope to emphasize the connection between established cardiovascular risk factors, cardiac remodeling and AF, with a view to promote strategies for AF prevention.

Entities:  

Mesh:

Year:  2011        PMID: 21562376      PMCID: PMC3220939          DOI: 10.1097/HPC.0b013e31820e1a4b

Source DB:  PubMed          Journal:  Crit Pathw Cardiol        ISSN: 1535-2811


  69 in total

1.  Electrical interaction of mechanosensitive fibroblasts and myocytes in the heart.

Authors:  A Kamkin; I Kiseleva; I Lozinsky; H Scholz
Journal:  Basic Res Cardiol       Date:  2005-04-18       Impact factor: 17.165

2.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

Authors:  D Li; S Fareh; T K Leung; S Nattel
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

Review 3.  Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets.

Authors:  Joachim R Ehrlich; Stanley Nattel; Stefan H Hohnloser
Journal:  J Cardiovasc Electrophysiol       Date:  2002-04

4.  Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension.

Authors:  S Ciaroni; L Cuenoud; A Bloch
Journal:  Am Heart J       Date:  2000-05       Impact factor: 4.749

5.  Improving survival for patients with atrial fibrillation and advanced heart failure.

Authors:  W G Stevenson; L W Stevenson; H R Middlekauff; G C Fonarow; M A Hamilton; M A Woo; L A Saxon; P D Natterson; A Steimle; J A Walden; J H Tillisch
Journal:  J Am Coll Cardiol       Date:  1996-11-15       Impact factor: 24.094

Review 6.  Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data.

Authors:  Tim T Issac; Hisham Dokainish; Nasser M Lakkis
Journal:  J Am Coll Cardiol       Date:  2007-11-05       Impact factor: 24.094

7.  Obstructive sleep apnea and the recurrence of atrial fibrillation.

Authors:  Ravi Kanagala; Narayana S Murali; Paul A Friedman; Naser M Ammash; Bernard J Gersh; Karla V Ballman; Abu S M Shamsuzzaman; Virend K Somers
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

Review 8.  Status of the epidemiology of atrial fibrillation.

Authors:  William B Kannel; Emelia J Benjamin
Journal:  Med Clin North Am       Date:  2008-01       Impact factor: 5.456

9.  The epidemiology of heart failure: the Framingham Study.

Authors:  K K Ho; J L Pinsky; W B Kannel; D Levy
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

10.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD).

Authors:  G Torre-Amione; S Kapadia; C Benedict; H Oral; J B Young; D L Mann
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

View more
  13 in total

1.  Drier air, lower temperatures, and triggering of paroxysmal atrial fibrillation.

Authors:  Jennifer L Nguyen; Mark S Link; Heike Luttmann-Gibson; Francine Laden; Joel Schwartz; Benjamin S Wessler; Murray A Mittleman; Diane R Gold; Douglas W Dockery
Journal:  Epidemiology       Date:  2015-05       Impact factor: 4.822

Review 2.  The Relationship Between Atrial Fibrillation and Chronic Kidney Disease : Epidemiologic and Pathophysiologic Considerations for a Dual Epidemic.

Authors:  David D McManus; Jane S Saczynski; Jeanine A Ward; Khushleen Jaggi; Peter Bourrell; Chad Darling; Robert J Goldberg
Journal:  J Atr Fibrillation       Date:  2012-06-15

Review 3.  Treatment Considerations for a Dual Epidemic of Atrial Fibrillation and Heart Failure.

Authors:  Parikshit S Sharma; David J Callans
Journal:  J Atr Fibrillation       Date:  2013-08-31

4.  No decline in the risk of heart failure after incident atrial fibrillation: A community study assessing trends overall and by ejection fraction.

Authors:  Alanna M Chamberlain; Bernard J Gersh; Alvaro Alonso; Stephen L Kopecky; Jill M Killian; Susan A Weston; Véronique L Roger
Journal:  Heart Rhythm       Date:  2017-01-21       Impact factor: 6.343

5.  High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study.

Authors:  Christopher Papandreou; Pablo Hernández-Alonso; Mònica Bulló; Miguel Ruiz-Canela; Jun Li; Marta Guasch-Ferré; Estefanía Toledo; Clary Clish; Dolores Corella; Ramon Estruch; Montserrat Cofán; Montserrat Fitó; Cristina Razquin; Fernando Arós; Miquel Fiol; José M Santos-Lozano; Lluís Serra-Majem; Liming Liang; Miguel A Martínez-González; Frank B Hu; Jordi Salas-Salvadó
Journal:  J Nutr       Date:  2020-11-19       Impact factor: 4.798

Review 6.  An update on the prognosis of patients with atrial fibrillation.

Authors:  David D McManus; Michiel Rienstra; Emelia J Benjamin
Journal:  Circulation       Date:  2012-09-04       Impact factor: 29.690

7.  Modulation of both activator protein-1 and nuclear factor-kappa B signal transduction of human T cells by amiodarone.

Authors:  Shu-Meng Cheng; Wei-Hsiang Lin; Chin-Sheng Lin; Ling-Jun Ho; Tsung-Neng Tsai; Chun-Hsien Wu; Jenn-Haung Lai; Shih-Ping Yang
Journal:  Exp Biol Med (Maywood)       Date:  2014-07-29

8.  Speckle echocardiographic left atrial strain and stiffness index as predictors of maintenance of sinus rhythm after cardioversion for atrial fibrillation: a prospective study.

Authors:  Amir Y Shaikh; Abhishek Maan; Umar A Khan; Gerard P Aurigemma; Jeffrey C Hill; Jennifer L Kane; Dennis A Tighe; Eric Mick; David D McManus
Journal:  Cardiovasc Ultrasound       Date:  2012-12-03       Impact factor: 2.062

9.  Intracellular lactate signaling cascade in atrial remodeling of mitral valvular patients with atrial fibrillation.

Authors:  Jing Xu; Xiaohan Xu; Linjie Si; Lei Xue; Shijiang Zhang; Jianwei Qin; Yanhu Wu; Yongfeng Shao; Yijiang Chen; Xiaowei Wang
Journal:  J Cardiothorac Surg       Date:  2013-03-01       Impact factor: 1.637

10.  Low efficacy of cardioversion of persistent atrial fibrillation with the implantable cardioverter-defibrillator.

Authors:  I Limantoro; K Vernooy; B Weijs; R Pisters; L Debie; H J Crijns; Y Blaauw
Journal:  Neth Heart J       Date:  2013-12       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.